Back

Introduction and welcome

31 August 2019 (15:30 - 15:35)
Organised by:
Congress Presentation Part of: Paradigm shift in DOAC reversal - What are the current therapeutic options? Pharmacology and Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Associate Professor Erik Lerkevang Grove

Aarhus University Hospital, Aarhus (Denmark)

4 More presentations in this session

Presentation thumbnail
DOAC-related bleeding: demographics, risk factors & guidelines .
Professor J. Oldgren (Uppsala, SE)
Presentation thumbnail
Specific reversal agent for FXa - Inhibitor treatment - What the study data reveals? .
Doctor A. Cohen (London, GB)
Presentation thumbnail
From clinical evidence to patient management- How to reverse DOAC in clinical practice .
Professor S. Middeldorp (Amsterdam, NL)
Presentation thumbnail
Plenary questions and discussion
Professor E. Lindhoff-Last (DE) Associate Professor E. Grove (Aarhus, DK)

Access the full session

Session thumbnail
Paradigm shift in DOAC reversal - What are the current therapeutic options?

The Event

Event poster

ESC Congress 2019

31 August 2019 15:30 CET
You may be interested in
thumbnail
Congress Presentation
Dynamics of indicators of central hemodynamics and arterial wall rigidity during the background of combination therapy with amlodipine/ valsartan in patients with arterial hypertension
thumbnail
Congress Session
Challenges in hypertension management
thumbnail
ESC TV Today
Episode 7: Coronary spasm - Sex differences in heart failure

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources